— Know what they know.
Not Investment Advice

AMLX NASDAQ

Amylyx Pharmaceuticals, Inc.
1W: -0.9% 1M: -8.1% 3M: +38.6% YTD: +137.2% 1Y: +89.3% 3Y: +63.7%
$28.30
+1.21 (+4.47%)
After Hours: $27.48 (-0.82, -2.92%)
Weekly Expected Move ±6.1%
$24 $26 $27 $29 $31
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $3.4B mcap · 97M float · 2.19% daily turnover · Short 49% of daily vol
Credit Risk of going bust: lower than 78% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Amylyx Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $5.3M against a stock market value of $3.40B.
Distance to default 9.13 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.6M (short-term plus half of long-term), stock volatility 75.9%; Altman Z'' 1.60. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☀️
Sunny
+60.5% YTD avg
Midterm Year
☀️
Sunny
+98.5% YTD avg
2026 Now
☀️
Sunny
Above typical
20yr Avg YTD
+60.5%
Day 206 of 252
Midterm Year YTD
+98.5%
Presidential cycle avg
2026 YTD
+147.8%
Above 20yr avg
Typical Vol
67%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+3.4%
Midterm
☀️
+9.7%
80% win 79% vol
Feb
20yr
💨
+11.4%
Midterm
☀️
+49.4%
60% win 78% vol
Mar
20yr
⛈️
-31.9%
Midterm
⛈️
-23.9%
20% win 159% vol
Apr
20yr
⛈️
-33.1%
Midterm
⛈️
-57.7%
40% win 71% vol
May
20yr
⛈️
-30.9%
Midterm
⛈️
-33.5%
20% win 74% vol
Jun
20yr
💨
-11.3%
Midterm
☀️
+22.9%
80% win 98% vol
Jul
20yr
💨
+4.5%
Midterm
☀️
+37.4%
100% win 72% vol
Aug
20yr
💨
+6.2%
Midterm
☁️
-0.9%
60% win 112% vol
Sep
20yr
💨
+48.4%
Midterm
☀️
+81.6%
60% win 108% vol
Oct
20yr
💨
+56.4%
Midterm
☀️
+90.2%
60% win 67% vol
Now: -2.8%
Nov
20yr
💨
+58.8%
Midterm
☀️
+105.8%
75% win 89% vol
Dec
20yr
⛈️
-12.7%
Midterm
⛈️
-3.7%
25% win 46% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +147.8%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms